📜Upcoming FOIA Advisory Committee Meeting for Business Insights
We are announcing an upcoming Freedom of Information Act (FOIA) Advisory Committee meeting in accordance with the Federal Advisory Committee Act and the second United States Open Government National Action Plan.
Learn More🚨Impact of Repeal on Minority Biomedical Research Support Program
The Department of Health and Human Services (HHS), in consultation with the National Institutes of Health (NIH), is repealing the regulation relating to the Minority Biomedical Research Support (MBRS) program in compliance with Executive Order (E.O.) 14173 (Ending Illegal Discrimination and Restoring Merit-Based Opportunity) and E.O. 14151 (Ending Radical and Wasteful Government DEI Programs and Preferencing), and to abide by Supreme Court precedent. HHS remains committed to ensuring equal treatment under the law throughout its grant programs.
Learn More📝VA Notice on Information Collection for Statement of Disappearance
In compliance with the Paperwork Reduction Act (PRA) of 1995, this notice announces that the Veterans Benefits Administration, Department of Veterans Affairs, will submit the collection of information abstracted below to the Office of Management and Budget (OMB) for review and comment. The PRA submission describes the nature of the information collection and its expected cost and burden, and it includes the actual data collection instrument.
Learn More🎓Notice on Foreign Schools Eligibility for Title IV Programs
In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department is proposing an extension without change to a currently approved information collection request (ICR).
Learn More📈Nasdaq PHLX Flex Options Trading Rule Change Overview
The SEC has published a notice regarding Nasdaq PHLX's proposed rules governing electronic FLEX Options trading. This includes measures for customizing contract terms, aligning with enhanced technology for better market performance and enabling tailored investment strategies. The implementation is designed to improve trading flexibility and market efficiency across investment approaches.
Learn More💊FDA Notice on LUMISIGHT Patent Extension Review Period
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for LUMISIGHT and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Learn More💊FDA Notice on CAMZYOS Patent Extension and Review Period
The Food and Drug Administration (FDA or the Agency) published a notice in the Federal Register of February 29, 2024. After review of the calculation of the applicable regulatory review period of the biologic product CAMZYOS (U.S. patent numbers 9,181,200; 9,585,883) in that notice, FDA has determined that a revision of the supplementary information section is warranted. This notice corrects the applicable regulatory review period language.
Learn More🚤Coast Guard Information Collection Request for Aquaculture Operations
In compliance with the Paperwork Reduction Act of 1995, the U.S. Coast Guard intends to submit an Information Collection Request (ICR) to the Office of Management and Budget (OMB), Office of Information and Regulatory Affairs (OIRA), requesting an extension of its approval for the following collection of information: 1625-0126, Requirements for Vessels that Perform Certain Aquaculture Support Operations; without change. Our ICR describes the information we seek to collect from the public. Before submitting this ICR to OIRA, the Coast Guard is inviting comments as described below.
Learn More🧬Meeting Update for National Advisory Council on Human Genome Research
The National Institutes of Health has announced a change in the timing of the National Advisory Council for Human Genome Research meeting. The meeting is set for September 16, 2025, now starting at 09
Learn More📅CPAAC Meeting Announcement - Federal Communications Commission
In this document, the Commission announces the first meeting of the current term of its Consumer Protection and Accessibility Advisory Committee (CPAAC or Committee).
Learn More